Are We Headed for a New Era of Malaria Drug Resistance? Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s ...

The emergence of drug-resistant parasites thwarts efforts to control human malaria. How can we understand the mechanism of drug-resistance evolution and build a strategy to delay it? So far, no ...

Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number ...

The once-daily, oral combination has been tested in a phase 2b trial involving 500 patients with acute uncomplicated malaria due to Plasmodium falciparum infection – in other words patients who ...

Researchers from the universities in Konstanz and Vienna have discovered a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhea. These substances ...

Plasmodium parasites that cause Malaria infect hundreds of millions each year, but we still lack a full understanding of how they transmit from host to host and the conditions that enable Plasmodium ...

When it comes to evading the human immune system, the malaria parasite is a master of stealth. But a recent discovery could provide the means to blowing its cover. A team of researchers—led by Prof.

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

A new drug called nitisinone, which makes human blood poisonous to mosquitoes, could be a vital new tool to fight malaria.